otlc: the balance sheet

MyFinsight

For the quarter ending 2025-06-30, OTLC has $26,680,807 in assets. $19,286,912 in debts. $88,022 in cash and cash equivalents.

Unit: Dollar

Balance Sheets	2025-06-30
Restricted cash	20,000
Prepaid & other current assets	10,594
Cash	88,022
Accounts receivable	18,976
Total current assets	137,592
In process r&d	1,101,760
Investment in gmp bio at fair value	22,653,225
Goodwill, net of impairment	2,788,230
Total assets	26,680,807

Accounts payable and accrued liabilities	2,487,234
Convertible debt-Related Party	3,608,634
Convertible debt-Nonrelated Party	9,940,174
Derivative liability on notes	278,786
Contingent consideration	2,625,000
Accounts payable to related party-Related Party	347,084
Total current liabilities	19,286,912
Total liabilities	19,286,912
Accumulated deficit	-38,061,528
Common stock, .01 par value 750,000,000 shares authorized 408,292,720 and 407,289,888 issued and outstanding, respectively	4,082,927
Additional paid-in capital	42,279,570
Total oncotelic therapeutics, inc. stockholders equity	8,300,969
Non-controlling interests	-907,074
Total stockholders equity	7,393,895
Total liabilities and stockholders equity	26,680,807